Viewing Study NCT05833893


Ignite Creation Date: 2025-12-25 @ 1:01 AM
Ignite Modification Date: 2025-12-25 @ 11:15 PM
Study NCT ID: NCT05833893
Status: RECRUITING
Last Update Posted: 2023-04-27
First Post: 2023-02-25
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Clinical Study of XPO1 Inhibitor Selinexor Combined With COPL in Newly Diagnosed Advanced NK/T-cell Lymphoma
Sponsor: Chinese PLA General Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module